Overview
The Melbourne Biomedical AI (MBAI) Consortium is a collaborative partnership of universities, health services, medical research institutes and other organisations aligned with the Melbourne Academic Centre for Health (MACH), committed to advancing the responsible use of artificial intelligence in biomedical research.
The MBAI Consortium exists to strengthen collaboration across organisations, accelerate the adoption of AI-enabled approaches, build capability, and support the development of shared infrastructure, frameworks and partnerships that enhance research and healthcare outcomes.
The Consortium seeks to position Melbourne as a nationally and internationally recognised leader in biomedical AI by fostering collaboration, innovation and responsible practice across the research and health ecosystem.
Activities of the Consortium are overseen by the MACH Strategic Translational Research and Platforms Committee.
MACH SUPPORT
Nick Walsh
The objectives of the Consortium are to:
- Infrastructure and Capability: Develop and promote shared biomedical AI research infrastructure, services and capability across member organisations
- Workforce Development: Build AI capability through collaborative training, shared resources and communities of practice
- Clinical and Research Integration: Foster collaboration between research organisations, health services and clinical leaders to support the application of AI in research and healthcare
- Governance and Collaboration: Promote best-practice governance, ethics, privacy and data stewardship, and support frameworks that enable multi-institutional collaboration
- Strategic Engagement: Pursue collaborative research, infrastructure and funding opportunities; engage with government, industry and the broader biomedical innovation ecosystem; and promote the Consortium’s activities, capabilities and achievements through shared communications and outreach